Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MEDP - Medpace Holdings Inc


IEX Last Trade
355.29
-10.650   -2.998%

Share volume: 655,768
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$365.94
-10.65
-2.91%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
73%
Profitability 87%
Dept financing 27%
Liquidity 51%
Performance 75%
Company vs Stock growth
vs
Performance
5 Days
-9.12%
1 Month
-6.08%
3 Months
-7.89%
6 Months
-11.87%
1 Year
31.09%
2 Year
135.39%
Key data
Stock price
$355.29
P/E Ratio 
32.43
DAY RANGE
N/A - N/A
EPS 
$10.64
52 WEEK RANGE
$227.21 - $459.77
52 WEEK CHANGE
$0.30
MARKET CAP 
11.014 B
YIELD 
N/A
SHARES OUTSTANDING 
31.002 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/21/2024
BETA 
1.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$275,530
AVERAGE 30 VOLUME 
$250,719
Company detail
CEO: August Troendle
Region: US
Website: http://investor.medpace.com/investor-overview
Employees: 5,385
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.

Recent news